ID16091A - Turunan 3,4-disubstitusi feniletanolaminotetralin karboksamida - Google Patents

Turunan 3,4-disubstitusi feniletanolaminotetralin karboksamida

Info

Publication number
ID16091A
ID16091A IDP970478A ID970478A ID16091A ID 16091 A ID16091 A ID 16091A ID P970478 A IDP970478 A ID P970478A ID 970478 A ID970478 A ID 970478A ID 16091 A ID16091 A ID 16091A
Authority
ID
Indonesia
Prior art keywords
carbon atom
amino
configuration
pheniletanolaminotetralin
carboxamide
Prior art date
Application number
IDP970478A
Other languages
English (en)
Indonesian (id)
Inventor
Makio Kitazawa
Kosuke Okazaki
Tetsuro Tamai
Masaru Saito
Nobuyuki Tanaka
Hiroaki Kobayashi
Ken Kikuchi
Hideyuki Muranaka
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13386565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID16091(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of ID16091A publication Critical patent/ID16091A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
IDP970478A 1996-02-19 1997-02-19 Turunan 3,4-disubstitusi feniletanolaminotetralin karboksamida ID16091A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6888596 1996-02-19

Publications (1)

Publication Number Publication Date
ID16091A true ID16091A (id) 1997-09-04

Family

ID=13386565

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970478A ID16091A (id) 1996-02-19 1997-02-19 Turunan 3,4-disubstitusi feniletanolaminotetralin karboksamida

Country Status (24)

Country Link
US (1) US6133266A (pl)
EP (1) EP0882704B1 (pl)
JP (1) JP3892045B2 (pl)
KR (1) KR100491633B1 (pl)
CN (1) CN1100032C (pl)
AT (1) ATE225767T1 (pl)
AU (1) AU725042B2 (pl)
BR (1) BR9707566B1 (pl)
CA (1) CA2245490C (pl)
CZ (1) CZ293974B6 (pl)
DE (1) DE69716242T2 (pl)
DK (1) DK0882704T3 (pl)
EA (1) EA002143B1 (pl)
ES (1) ES2184989T3 (pl)
HU (1) HU229400B1 (pl)
ID (1) ID16091A (pl)
MY (1) MY123853A (pl)
NO (1) NO323095B1 (pl)
NZ (1) NZ331445A (pl)
PL (1) PL186411B1 (pl)
PT (1) PT882704E (pl)
SG (1) SG72727A1 (pl)
TW (1) TW375604B (pl)
WO (1) WO1997030023A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009001A1 (fr) * 1997-08-19 1999-02-25 Kissei Pharmaceutical Co., Ltd. Derives de phenylethanolaminotetraline et bronchodilatateurs
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
GB9913083D0 (en) * 1999-06-04 1999-08-04 Novartis Ag Organic compounds
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
FR2809725B1 (fr) * 2000-06-06 2004-05-07 Sanofi Synthelabo Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant
GB0029562D0 (en) 2000-12-04 2001-01-17 Novartis Ag Organic compounds
US20060052458A1 (en) * 2003-01-22 2006-03-09 Kissei Pharmaceutical Co., Ltd. Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
WO2006054514A1 (ja) * 2004-11-19 2006-05-26 Kissei Pharmaceutical Co., Ltd. 神経因性疼痛の予防又は治療用医薬組成物
EP1813285A4 (en) * 2004-11-19 2010-06-09 Kissei Pharmaceutical PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST NEUROPATHIC PAIN
EP2098511A1 (en) 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
JP2013511528A (ja) * 2009-11-18 2013-04-04 メディシノバ,インコーポレーテッド 喘息の急性憎悪の治療及びそれに罹患した患者の入院の可能性の低減
BR112012022619A2 (pt) * 2010-03-08 2015-10-20 Medicinova Inc composições, métodos, e meios para tratamento da dismenorreia
JP5841994B2 (ja) * 2010-04-08 2016-01-13 メディシノヴァ, インコーポレイテッド. 過敏性腸症候群の処置方法及びその治療用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107827D0 (en) * 1991-04-12 1991-05-29 Fujisawa Pharmaceutical Co New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL104567A (en) * 1992-02-03 1997-03-18 Fujisawa Pharmaceutical Co Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO1993018007A1 (fr) * 1992-03-13 1993-09-16 Tokyo Tanabe Company Limited Nouveau derive de carbostyrile

Also Published As

Publication number Publication date
KR100491633B1 (ko) 2005-09-09
PL186411B1 (pl) 2004-01-30
SG72727A1 (en) 2000-05-23
NO983777L (no) 1998-10-19
CN1216526A (zh) 1999-05-12
CZ293974B6 (cs) 2004-09-15
ES2184989T3 (es) 2003-04-16
BR9707566A (pt) 1999-07-27
NO983777D0 (no) 1998-08-18
EP0882704B1 (en) 2002-10-09
CN1100032C (zh) 2003-01-29
AU2001497A (en) 1997-09-02
EP0882704A4 (en) 2000-06-14
KR19990082638A (ko) 1999-11-25
EA002143B1 (ru) 2001-12-24
TW375604B (en) 1999-12-01
JP3892045B2 (ja) 2007-03-14
NZ331445A (en) 2000-01-28
BR9707566B1 (pt) 2010-08-10
HU229400B1 (en) 2013-12-30
WO1997030023A1 (en) 1997-08-21
CZ252398A3 (cs) 1998-12-16
EA199800644A1 (ru) 1999-02-25
MY123853A (en) 2006-06-30
CA2245490A1 (en) 1997-08-21
CA2245490C (en) 2005-10-25
HUP9900621A3 (en) 1999-11-29
AU725042B2 (en) 2000-10-05
DK0882704T3 (da) 2003-02-17
DE69716242T2 (de) 2003-07-24
DE69716242D1 (de) 2002-11-14
EP0882704A1 (en) 1998-12-09
US6133266A (en) 2000-10-17
HUP9900621A2 (hu) 1999-08-30
NO323095B1 (no) 2007-01-02
PT882704E (pt) 2003-02-28
PL328530A1 (en) 1999-02-01
ATE225767T1 (de) 2002-10-15

Similar Documents

Publication Publication Date Title
ES2141137T3 (es) Agentes terapeuticos para la enfermedad de parkinson.
DE69716242D1 (de) 3,4-disubstituierte phenylethanolaminotetralin-carboxamid-derivate
EA200000481A1 (ru) Производные гидроксамовой кислоты в качестве ингибиторов металлопротеаз матрикса (мпм)
PT93066A (pt) Processo para a preparacao de derivados heterociclicos contendo nucleos bengenicos fundidos com nucleos monoazotados substituidos e de composicoes farmaceuticas que os contem
DE69215694D1 (de) Benzamid-derivate
WO1996005166A1 (en) Substituted amine derivative and medicinal composition containing the same
NO913023L (no) Nye bicykliske aminosubstituerte forbindelser
NO984699L (no) Fenyletanolamino-tetralinkarboks-amid-derivater
EP0919233B8 (en) Therapeutic agent for kidney diseases
ES2070962T3 (es) N-hidroxi-dibenzo(b,e)oxepin-alquilaminas y -amidas de acido alcanoico, compuestos analogos heterociclicos relacionados, un procedimiento para su preparacion y su uso en la preparacion de medicamentos.
CA2251090A1 (en) Phenylethanolaminotetralincarboxamide derivatives
ES2060056T3 (es) Derivados de 3-isoxazolonas, su preparacion y su utilizacion en terapeutica.
ECSP972209A (es) Nuevos compuestos, procedimientos para su preparacion, composiciones, farmaceuticas y su uso en terapia